CARGO Therapeutics (CRGX) Competitors $14.90 +1.39 (+10.29%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CRGX vs. HCM, CPRX, AGIO, PTGX, IOVA, AMRX, LBPH, NAMS, IDYA, and CNTAShould you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include HUTCHMED (HCM), Catalyst Pharmaceuticals (CPRX), Agios Pharmaceuticals (AGIO), Protagonist Therapeutics (PTGX), Iovance Biotherapeutics (IOVA), Amneal Pharmaceuticals (AMRX), Longboard Pharmaceuticals (LBPH), NewAmsterdam Pharma (NAMS), IDEAYA Biosciences (IDYA), and Centessa Pharmaceuticals (CNTA). These companies are all part of the "pharmaceutical products" industry. CARGO Therapeutics vs. HUTCHMED Catalyst Pharmaceuticals Agios Pharmaceuticals Protagonist Therapeutics Iovance Biotherapeutics Amneal Pharmaceuticals Longboard Pharmaceuticals NewAmsterdam Pharma IDEAYA Biosciences Centessa Pharmaceuticals HUTCHMED (NASDAQ:HCM) and CARGO Therapeutics (NASDAQ:CRGX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation. Do analysts prefer HCM or CRGX? HUTCHMED currently has a consensus price target of $19.00, suggesting a potential upside of 32.77%. CARGO Therapeutics has a consensus price target of $31.80, suggesting a potential upside of 113.42%. Given CARGO Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe CARGO Therapeutics is more favorable than HUTCHMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50CARGO Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is HCM or CRGX more profitable? HUTCHMED's return on equity of 0.00% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets HUTCHMEDN/A N/A N/A CARGO Therapeutics N/A -38.16%-33.94% Does the MarketBeat Community believe in HCM or CRGX? HUTCHMED received 301 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 66.32% of users gave HUTCHMED an outperform vote. CompanyUnderperformOutperformHUTCHMEDOutperform Votes31566.32% Underperform Votes16033.68% CARGO TherapeuticsOutperform Votes14100.00% Underperform VotesNo Votes Which has preferable earnings & valuation, HCM or CRGX? HUTCHMED has higher revenue and earnings than CARGO Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHUTCHMED$420.26M5.94$100.78MN/AN/ACARGO TherapeuticsN/AN/A-$98.15M-$4.26-3.50 Do institutionals and insiders hold more shares of HCM or CRGX? 8.8% of HUTCHMED shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 3.6% of HUTCHMED shares are held by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to HCM or CRGX? In the previous week, CARGO Therapeutics had 3 more articles in the media than HUTCHMED. MarketBeat recorded 4 mentions for CARGO Therapeutics and 1 mentions for HUTCHMED. HUTCHMED's average media sentiment score of 1.05 beat CARGO Therapeutics' score of 0.39 indicating that HUTCHMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CARGO Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryHUTCHMED beats CARGO Therapeutics on 7 of the 13 factors compared between the two stocks. Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRGX vs. The Competition Export to ExcelMetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$685.82M$2.94B$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E Ratio-3.5046.7391.3417.19Price / SalesN/A411.851,116.59116.80Price / CashN/A182.1042.6437.86Price / Book1.513.894.794.78Net Income-$98.15M-$42.21M$120.07M$225.60M7 Day Performance8.44%-2.14%-1.89%-1.24%1 Month Performance-5.28%4.21%11.45%3.36%1 Year Performance-25.43%18.40%30.61%16.58% CARGO Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRGXCARGO Therapeutics1.4673 of 5 stars$14.90+10.3%$31.80+113.4%-20.0%$685.82MN/A-3.50116High Trading VolumeHCMHUTCHMED2.5943 of 5 stars$14.94-4.1%$19.00+27.2%-15.0%$2.60B$838M0.001,988Positive NewsCPRXCatalyst Pharmaceuticals4.6873 of 5 stars$21.78+1.9%$31.14+43.0%+48.7%$2.60B$398.20M18.12167AGIOAgios Pharmaceuticals4.2912 of 5 stars$44.19+13.4%$56.33+27.5%+53.6%$2.52B$32.87M3.73390Analyst ForecastPTGXProtagonist Therapeutics3.582 of 5 stars$41.45+0.9%$53.78+29.7%+100.0%$2.47B$60M15.44125News CoveragePositive NewsIOVAIovance Biotherapeutics4.005 of 5 stars$7.90+0.9%$22.33+182.7%+2.8%$2.41B$1.19M-5.25500AMRXAmneal Pharmaceuticals2.8869 of 5 stars$7.75-1.0%$10.00+29.0%+47.1%$2.40B$2.68B-11.387,700Analyst DowngradeNews CoveragePositive NewsLBPHLongboard Pharmaceuticals0.6607 of 5 stars$59.98+0.0%$59.56-0.7%+986.6%$2.34BN/A-26.9020NAMSNewAmsterdam Pharma2.8425 of 5 stars$24.50-0.8%$36.20+47.8%+142.4%$2.26B$33.59M0.0057Insider TradeAnalyst RevisionGap DownIDYAIDEAYA Biosciences4.3209 of 5 stars$25.95+3.0%$53.67+106.8%-23.7%$2.24B$3.92M-10.8180Analyst ForecastCNTACentessa Pharmaceuticals3.0004 of 5 stars$16.38-1.1%$25.83+57.7%+131.0%$2.16B$6.85M-10.8372Insider Trade Related Companies and Tools Related Companies HCM Competitors CPRX Competitors AGIO Competitors PTGX Competitors IOVA Competitors AMRX Competitors LBPH Competitors NAMS Competitors IDYA Competitors CNTA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRGX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.